See More Hear More Watch More Hear More Get on iTunes
deletedatc deletedatc

Turing Pharmaceuticals Retreats Fr Price Increase

Turing Pharmaceutical CEO Martin Shkreli has backed down on his plan for an astronomical price increase on a drug used to treat a deadly parasitic infection. The company did not say what the new price would be, but presumably less than the $750 a pill it had planned to charge. The move illustrates how Shkreli is more Wall Street speculator than pharmaceutical entrepreneur. More Info: http://www.npr.org/2015/09/23/442907028/turing-pharmaceuticals-retreats-from-plan-to-raise-price-of-daraprim #FullNewsAudioAvailable #NPR

UP NEXT

More from